dsRNA, but also induces apoptosis selectively in cancer cells. Our analysis by
immunohistochemistry revealed that TLR3 is frequently overexpressed in 130 non-small cell
lung cancer (NSCLC) patients' samples compared with normal bronchial epithelium (P<
0.0001, Mann–Whitney test), supporting the therapeutic potential of TLR3 ligand for this type
of cancer. However, a proportion of TLR3-expressing cancer cell lines, including NSCLC …